* Pediatrix Medical Group Inc MD.N reported quarterly
adjusted
earnings of 32 cents per share for the quarter ended in
September, lower than the same quarter last year, when the
company reported EPS of 40 cents. The mean expectation of
eight analysts for the quarter was for earnings of 43 cents per
share. Wall Street expected results to range from 42 cents to 46
cents per share.
* Revenue rose 3.4% to $506.61 million from a year ago;
analysts
expected $508.25 million.
* Pediatrix Medical Group Inc's reported EPS for the quarter
was
26 cents.
* The company reported quarterly net income of $21.39
million.
* Pediatrix Medical Group Inc shares had fallen by 11.8%
this
quarter and lost 24.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.5%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"
Wall Street's median 12-month price target for Pediatrix Medical
Group Inc is $14.50
This summary was machine generated from LSEG data November 2 at
01:31 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.43 0.32 Missed
Jun. 30 2023 0.40 0.39 Missed
Mar. 31 2023 0.23 0.23 Met
Dec. 31 2022 0.48 0.47 Missed